Switzerland· 67306001

Elmiron

A pentosan polysulfate sodium product containing heparinoidum (natrii pentosani polysulfas), registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC G04BX15

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedElmironATCG04BX15REGISTER NO.67306001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Pentosan polysulfate sodium is registered in 10 of 19 countries.

Countries holding a registration under ATC G04BX15 (pentosan polysulfate sodium), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Pentosan polysulfate sodium · ATC G04BX15

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pentosan polysulfate sodium costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • Switzerland: $19.03 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Pentosan polysulfate sodium · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$19.03
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
heparinoidum (natrii pentosani polysulfas)
Manufacturer
—
Country
Switzerland (CH)
ATC code
G04BX15
ATC class
Pentosan polysulfate sodium
Defined daily dose
0.3 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680673060018
    Ds 90 Stk
    CHF 473.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

74 interactions on record for pentosan polysulfate sodium.

Graded by severity as the source publishes them — 74 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Pentosan polysulfate sodium · interactions on record

74 records

  • 74 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • HeparinB01AB01moderate
  • Antithrombin IIIB01AB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentosan polysulfate sodium in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentosan polysulfate sodium products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cedff57a-f408-443f-a01e-93632478bccd
GET /v1/drugs/cedff57a-f408-443f-a01e-93632478bccd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "natrii pentosanpolysulfas 100 mg",
  "valid_from": "2026-04-01",
  "limitations": "[{\"description\":\"Nach vorgängiger Kostengutsprache zur symptomatischen Behandlung von persistierenden oder rezidivierenden Schmerzen / unangenehmes Gefühl/Druckgefühl, welche als mit der Blase zusammenhängend empfunden werden und begleitet von Symptomen des unteren Harntraktes (Pollakisurie\\n(10x/Tag) oder Drang bedingt durch Schmerzen, Druckgefühle oder Missempfinden ohne Angst vor Inkontinenz) beim Syndrom der schmerzhaften Harnblase (BPS) bei Erwachsenen mit einer Dauer von mehr als 3 Monaten, sofern:<br>\\n- Die Einleitung der Behandlung nach Ausschluss eines HWI oder anderer erkennbarer Ursachen durch einen Facharzt der Urologie oder Gynäkologie mit Schwerpunkt Urogynäkologie erfolgt<br>\\n- Hunner Läsionen und/oder Glomerulationen zystoskopisch nachgewiesen wurden<br>\\n- die Erkrankung nicht auf orale Therapien wie klassische und neuropathische Analgetika, Anticholinergika, Antihistaminika und klassische nicht-medikamentöse Ansätze angesprochen hat oder diese nach Ansicht des behandelnden Facharztes nicht indiziert sind<br>\\n- keine gleichzeitige Behandlung mit Blaseninstillationen stattfindet.<br>\\nIst nach 6 Monaten Behandlung keine Besserung ersichtlich, soll auf eine andere geeignetere Therapie umgestellt werden. Bei Ansprechen soll die Behandlung alle 3-6 Monate neu evaluiert werden.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"20980.01\\t\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-04-01\",\"validTo\":\"2029-03-31\"}]",
  "galenic_form": "Kaps 100 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2022-12-01",
  "self_retention_pct": 10
}

See everything about pentosan polysulfate sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.